Trial intelligence / Profile preview

Topical tranexamic acid with and without laser for melasma

IRCT2016011626047N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of tranexamic acid in melasma (2 arms), sponsored by Tehran University of Medical Sciences. Started Feb 2016; status: completed.

02

Drugs

tranexamic acid
03

Conditions

melasma

Beyond the preview

Go deeper on IRCT2016011626047N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016011626047N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call